FDA Notices of Judgment Collection, 1908-1966

Search

Start Over Collections Drugs and Devices, 1940-1963 ✖Remove constraint Collections: Drugs and Devices, 1940-1963

170. 917. Adulteration and misbranding of digitalis tablets, misbranding of cascara compound tablets, alleged adulteration of cascara compound tablets, and alleged adulteration and misbranding of posterior pituitary solution. U. S. v. Buffalo Pharmacal Co., Inc., and Joseph H. Dotterweich. Counts charging adulteration of cascara compound tablets and adulteration and misbranding of posterior pituitary solution nolle prossed. Pleas of not guilty. Tried to the court and jury. Verdict of guilty as to the individual defendant; disagreement as to the corporate defendant. Fine, 500 on each of 3 counts against individual defendant; payment of fines on counts 2 and 3 suspended and the individual defendant placed on probation. Judgment reversed on appeal to the Circuit Court of Appeals. Petition for Writ of Certiorari granted and decision rendered by Supreme Court reversing the judgment of the Circuit Court of Appeals.

Defendants:
Buffalo Pharmacal Co., Inc., and Joseph H. Dotterweich, secretary and general manager of the corporation
Issue Dates:
October 1944

174. 921. Adulteration of chorionic gonadotropic hormone. U. S. v. Abraham J. Blaivas, Murray Blaivas, Benjamin W. Feldman, and Emanuel Mandelbaum (Kings County Research Laboratories). Pleas of guilty. Fines of $100 against Benjamin W. Feldman, $300 against Murray Blaivas, and 500 each against Abraham J. Blaivas and Emanuel Mandelbaum. Sentence against each of the defendants of 6 months in prison suspended, and the defendants placed on probation for 18 months.

Defendants:
Abraham J. Blaivas, Murray Blaivas, Benjamin W. Feldman, and Emanuel Mandelbaum, copartners trading as the Kings County Research Laboratories, Brooklyn, N. Y.
Issue Dates:
October 1944